Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$27.58 - $40.0 $116,801 - $169,400
-4,235 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$27.98 - $40.0 $118,495 - $169,400
4,235 New
4,235 $157,000
Q2 2021

Aug 17, 2021

SELL
$32.22 - $41.5 $1.16 Million - $1.49 Million
-36,000 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$36.3 - $56.34 $1.31 Million - $2.03 Million
36,000 New
36,000 $1.53 Million

Others Institutions Holding IMCR

About Immunocore Holdings plc


  • Ticker IMCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,897,100
  • Market Cap $1.44B
  • Description
  • Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...
More about IMCR
Track This Portfolio

Track Sphera Funds Management Ltd. Portfolio

Follow Sphera Funds Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sphera Funds Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sphera Funds Management Ltd. with notifications on news.